Search Results  for 'MVIRb.ST'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Medivir AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

19 Apr 2014 Reuters Investment Profile 12 $20.00

Medivir AB (MVIR B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Medivir AB (MVIR B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Medivir is a pharmaceutical product ...

21 Apr 2014 GlobalData 45 $250.00

Wright Investors Service Comprehensive Report for Medivir AB

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

19 Apr 2014 Wright Reports 41 $75.00

Medivir AB (MVIR B) - Financial Analysis Review

Medivir AB (MVIR B) - Financial Analysis Review Summary Medivir is a pharmaceutical product manufacturer. The company d...

18 Mar 2014 GlobalData 34 $125.00

Medivir AB (MVIR B) - Financial Analysis Review

Medivir AB (MVIR B) - Financial Analysis Review Summary Medivir is a pharmaceutical product manufacturer. The company d...

10 Feb 2014 GlobalData 32 $125.00

Medivir AB (MVIR B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Medivir AB (MVIR B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Medivir is a pharmaceutical product ...

24 Jan 2014 GlobalData 45 $250.00

Medivir AB (MVIR B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Medivir AB (MVIR B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Medivir AB (Medivir) is a pharmaceut...

13 Dec 2013 GlobalData 52 $250.00

Medivir AB

Medivir AB - Company Report, is a source of comprehensive company data and information. The report covers the company’s stru...

26 Nov 2013 MarketLine (a Datamonitor Company) 43 $50.00

MEDIVIR - SIMEPREVIR BACKED BY ADCOM IN G1 PATIENTS

Medivir’s shares have come under pressure in the wake of last week’s AdCom for simeprevir, despite the committee’s unanimous ...

01 Nov 2013 Edison Investment Research 2 $10.00

Medivir AB (MVIR B) - Financial Analysis Review

Medivir AB (MVIR B) - Financial Analysis Review Summary Medivir AB (Medivir) is a pharmaceutical company. It focuses on...

17 Oct 2013 GlobalData 41 $125.00